miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response

This report identifies a new contribution of members of the miR-200 family to tumorigenesis. miR-200a and miR-141 specifically regulate p38α, contributing to the cellular modulation of oxidative stress responses. In this role, the miRs can accelerate ovarian tumorigenesis but also endow cancer cells...

Full description

Saved in:
Bibliographic Details
Published inNature medicine Vol. 17; no. 12; pp. 1627 - 1635
Main Authors Mateescu, Bogdan, Batista, Luciana, Cardon, Melissa, Gruosso, Tina, de Feraudy, Yvan, Mariani, Odette, Nicolas, André, Meyniel, Jean-Philippe, Cottu, Paul, Sastre-Garau, Xavier, Mechta-Grigoriou, Fatima
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.12.2011
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This report identifies a new contribution of members of the miR-200 family to tumorigenesis. miR-200a and miR-141 specifically regulate p38α, contributing to the cellular modulation of oxidative stress responses. In this role, the miRs can accelerate ovarian tumorigenesis but also endow cancer cells with increased sensitivity to ROS-inducing chemotherapy. This two-part effect is reflected on the distinct association of the miRs with patient survival and may be informative for treatment decisions. Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.
AbstractList Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials. [PUBLICATION ABSTRACT]
Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.
Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38a and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38a deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.
This report identifies a new contribution of members of the miR-200 family to tumorigenesis. miR-200a and miR-141 specifically regulate p38α, contributing to the cellular modulation of oxidative stress responses. In this role, the miRs can accelerate ovarian tumorigenesis but also endow cancer cells with increased sensitivity to ROS-inducing chemotherapy. This two-part effect is reflected on the distinct association of the miRs with patient survival and may be informative for treatment decisions. Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.
Audience Academic
Author Nicolas, André
de Feraudy, Yvan
Cottu, Paul
Mechta-Grigoriou, Fatima
Meyniel, Jean-Philippe
Cardon, Melissa
Sastre-Garau, Xavier
Mariani, Odette
Mateescu, Bogdan
Batista, Luciana
Gruosso, Tina
Author_xml – sequence: 1
  givenname: Bogdan
  surname: Mateescu
  fullname: Mateescu, Bogdan
  organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France
– sequence: 2
  givenname: Luciana
  surname: Batista
  fullname: Batista, Luciana
  organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France
– sequence: 3
  givenname: Melissa
  surname: Cardon
  fullname: Cardon, Melissa
  organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France
– sequence: 4
  givenname: Tina
  surname: Gruosso
  fullname: Gruosso, Tina
  organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France
– sequence: 5
  givenname: Yvan
  surname: de Feraudy
  fullname: de Feraudy, Yvan
  organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France
– sequence: 6
  givenname: Odette
  surname: Mariani
  fullname: Mariani, Odette
  organization: Department of Pathology, Institut Curie, Paris, France
– sequence: 7
  givenname: André
  surname: Nicolas
  fullname: Nicolas, André
  organization: Department of Pathology, Institut Curie, Paris, France
– sequence: 8
  givenname: Jean-Philippe
  surname: Meyniel
  fullname: Meyniel, Jean-Philippe
  organization: Institut Curie, Functional Genomic Platform
– sequence: 9
  givenname: Paul
  surname: Cottu
  fullname: Cottu, Paul
  organization: Department of Medical Oncology, Institut Curie
– sequence: 10
  givenname: Xavier
  surname: Sastre-Garau
  fullname: Sastre-Garau, Xavier
  organization: Department of Pathology, Institut Curie, Paris, France
– sequence: 11
  givenname: Fatima
  surname: Mechta-Grigoriou
  fullname: Mechta-Grigoriou, Fatima
  email: fatima.mechta-grigoriou@curie.fr
  organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22101765$$D View this record in MEDLINE/PubMed
BookMark eNqNkl1rHSEQhqWkNB8t_QdFKPTjYk91d3XXyxCaNBAIpB-U3ojHHTeGXT1RNyT_vi4nbbNwLoqggz7zDvM6h2jPeQcIvaZkRUnVfnLjqmS0fIYOKKt5QRvycy_HpGmLVjC-jw5jvCGEVISJF2i_LCmhDWcH6NdorwpaU6xch-e4JERhpRP2Dvs7FaxyOE2jD7YHB9FGvH7A2rsU_DBY12N_bzuV7B3gmALEiPO28S7CS_TcqCHCq8fzCH0__fzt5EtxcXl2fnJ8UWhOaSq44hQEFYQIQXhnlFHrynBFa1ZrLtakq9qKc9MaDkxD0-TmtGhrpuqGcy6qI_R2q7sJ_naCmOSNn4LLJSXNopQTUbb_qF4NIK0zPgWlRxu1PC6bWjCWPclUsYOaOw9qyJYbm68X_GoHn1cHo9U7Ez4uEmYn4T71aopRnn-9-n_28seSffeEvQY1pOvohynZ_BVL8P0W1MHHGMDITbCjCg_ZLDnPknSjnGcpk28efZ3WI3R_uT_Dk4EPWyDmJ9dDeGr8Uus3ss7Mmg
CitedBy_id crossref_primary_10_1002_bies_201200041
crossref_primary_10_1038_s41419_018_1093_9
crossref_primary_10_3389_fphar_2022_924817
crossref_primary_10_3390_cancers11020255
crossref_primary_10_3892_ijmm_2017_3324
crossref_primary_10_3892_ol_2014_1806
crossref_primary_10_1007_s11356_016_6253_9
crossref_primary_10_3389_fmolb_2024_1361601
crossref_primary_10_7314_APJCP_2014_15_20_8595
crossref_primary_10_1101_gr_139758_112
crossref_primary_10_1111_cas_14599
crossref_primary_10_3892_ol_2019_10934
crossref_primary_10_1089_ars_2013_5292
crossref_primary_10_1007_s10571_020_00920_4
crossref_primary_10_1007_s00018_022_04552_3
crossref_primary_10_3892_ol_2018_9444
crossref_primary_10_1016_j_yexcr_2013_04_011
crossref_primary_10_1186_1476_4598_13_221
crossref_primary_10_1007_s12032_023_02128_0
crossref_primary_10_3390_ijms222212530
crossref_primary_10_1002_jcb_25879
crossref_primary_10_1016_j_canlet_2013_01_042
crossref_primary_10_3892_ijo_2018_4497
crossref_primary_10_1016_j_ijheh_2014_01_001
crossref_primary_10_1093_carcin_bgs374
crossref_primary_10_1089_ars_2017_7276
crossref_primary_10_15252_emmm_201505891
crossref_primary_10_1371_journal_pone_0237066
crossref_primary_10_3390_ijms241310798
crossref_primary_10_1038_s41467_024_45595_3
crossref_primary_10_1002_cam4_5388
crossref_primary_10_1152_ajpcell_00137_2012
crossref_primary_10_1186_1476_4598_13_241
crossref_primary_10_1016_j_gene_2018_04_010
crossref_primary_10_1016_j_bbamcr_2013_06_026
crossref_primary_10_3390_medicines5010016
crossref_primary_10_1186_s12943_017_0582_2
crossref_primary_10_3390_v4112485
crossref_primary_10_3389_fonc_2022_999654
crossref_primary_10_1007_s10565_013_9250_5
crossref_primary_10_1089_ars_2023_0253
crossref_primary_10_15252_embj_201797345
crossref_primary_10_1007_s13402_018_00421_z
crossref_primary_10_1186_s12967_022_03553_x
crossref_primary_10_7314_APJCP_2014_15_17_7015
crossref_primary_10_1111_pbi_14095
crossref_primary_10_18632_oncotarget_18343
crossref_primary_10_3389_fphys_2015_00209
crossref_primary_10_1093_gerona_gly186
crossref_primary_10_1038_s41467_018_03348_z
crossref_primary_10_18632_oncotarget_7765
crossref_primary_10_3389_fcell_2021_690542
crossref_primary_10_3389_fonc_2016_00213
crossref_primary_10_1039_D0RA09237A
crossref_primary_10_1016_j_humpath_2015_06_013
crossref_primary_10_1016_j_jare_2020_11_006
crossref_primary_10_1016_j_prp_2020_153159
crossref_primary_10_1038_ncomms3977
crossref_primary_10_18632_oncotarget_13917
crossref_primary_10_1007_s00432_022_04101_2
crossref_primary_10_1038_s41598_021_83685_0
crossref_primary_10_1038_ncomms9959
crossref_primary_10_1371_journal_pone_0087782
crossref_primary_10_18632_oncotarget_16878
crossref_primary_10_1038_cddis_2014_573
crossref_primary_10_1586_erm_12_131
crossref_primary_10_3390_ijms19092687
crossref_primary_10_3390_ijms20236094
crossref_primary_10_18632_oncotarget_810
crossref_primary_10_1021_acsomega_3c04856
crossref_primary_10_1038_mt_2014_197
crossref_primary_10_1155_2019_6346529
crossref_primary_10_1038_mt_2014_79
crossref_primary_10_1038_s41388_019_0860_0
crossref_primary_10_1126_scisignal_aao4617
crossref_primary_10_1016_j_redox_2019_101137
crossref_primary_10_1038_s41467_018_07360_1
crossref_primary_10_1155_2013_173783
crossref_primary_10_1016_j_biopha_2020_110729
crossref_primary_10_17116_repro201521330_37
crossref_primary_10_3892_ijmm_2016_2719
crossref_primary_10_18632_oncotarget_20688
crossref_primary_10_1016_j_ijbiomac_2024_133305
crossref_primary_10_1002_gcc_22693
crossref_primary_10_1016_j_aquaculture_2021_736357
crossref_primary_10_4161_cc_26592
crossref_primary_10_1002_cam4_2692
crossref_primary_10_1016_j_redox_2020_101607
crossref_primary_10_3389_fgene_2019_00931
crossref_primary_10_1038_bjc_2016_124
crossref_primary_10_18632_oncotarget_3052
crossref_primary_10_1155_2017_5189138
crossref_primary_10_1242_jcs_133314
crossref_primary_10_1172_JCI63051
crossref_primary_10_1016_j_heliyon_2024_e28442
crossref_primary_10_1155_2019_1041583
crossref_primary_10_1186_s12935_020_01414_5
crossref_primary_10_1002_jgm_3116
crossref_primary_10_3390_ijms222111857
crossref_primary_10_1016_j_biocel_2013_03_001
crossref_primary_10_1155_2013_241780
crossref_primary_10_1158_0008_5472_CAN_14_3242
crossref_primary_10_1016_j_prp_2022_154222
crossref_primary_10_3390_biom12060781
crossref_primary_10_18311_ajprhc_2018_21486
crossref_primary_10_18632_oncotarget_9721
crossref_primary_10_1089_ars_2017_7229
crossref_primary_10_1177_2155179019873849
crossref_primary_10_3892_ol_2019_10736
crossref_primary_10_1002_jso_23572
crossref_primary_10_1007_s12079_020_00548_5
crossref_primary_10_1253_circj_CJ_14_1218
crossref_primary_10_3892_ijo_2012_1658
crossref_primary_10_1002_jcb_29237
crossref_primary_10_1016_j_biopha_2016_09_087
crossref_primary_10_1093_humupd_dmu060
crossref_primary_10_1186_s12943_022_01703_9
crossref_primary_10_1016_j_heliyon_2024_e30328
crossref_primary_10_1002_jcb_24589
crossref_primary_10_1016_j_jgg_2018_03_001
crossref_primary_10_3390_ijms23126702
crossref_primary_10_3389_fphys_2016_00342
crossref_primary_10_14336_AD_2021_0322
crossref_primary_10_1155_2021_3408937
crossref_primary_10_3892_ijo_2013_2189
crossref_primary_10_1172_JCI96313
crossref_primary_10_1124_mol_114_096743
crossref_primary_10_1039_C7MO00119C
crossref_primary_10_1016_j_dci_2016_06_004
crossref_primary_10_1016_j_canlet_2018_01_010
crossref_primary_10_3389_fphys_2019_00631
crossref_primary_10_1007_s11010_019_03547_2
crossref_primary_10_1016_j_critrevonc_2023_104220
crossref_primary_10_1016_j_lfs_2021_119263
crossref_primary_10_15430_JCP_2013_18_3_209
crossref_primary_10_1002_jcb_30471
crossref_primary_10_1016_j_cellsig_2023_110688
crossref_primary_10_1371_journal_pone_0174839
crossref_primary_10_1134_S0006297919110026
crossref_primary_10_3390_jcm6030029
crossref_primary_10_1002_emmm_201302732
crossref_primary_10_1186_s13048_019_0575_4
crossref_primary_10_1002_ijc_29568
crossref_primary_10_1038_nrc3265
crossref_primary_10_1016_j_jff_2023_105541
crossref_primary_10_3389_fimmu_2018_00757
crossref_primary_10_3390_ijms130911705
crossref_primary_10_1038_oncsis_2013_9
crossref_primary_10_1007_s12013_013_9801_7
crossref_primary_10_3390_ijms160816833
crossref_primary_10_3892_ijo_2017_4139
crossref_primary_10_3892_or_2015_4451
crossref_primary_10_1016_j_canlet_2019_10_021
crossref_primary_10_3892_mmr_2018_9108
crossref_primary_10_1016_j_dci_2014_03_015
crossref_primary_10_34108_eujhs_543409
crossref_primary_10_2217_epi_2019_0284
crossref_primary_10_1089_ars_2012_4820
crossref_primary_10_1155_2022_2365991
crossref_primary_10_1080_10715762_2017_1339871
crossref_primary_10_4161_cc_11_6_19665
crossref_primary_10_1155_2015_425708
crossref_primary_10_1371_journal_pone_0159686
crossref_primary_10_1016_j_canlet_2014_10_011
crossref_primary_10_18632_oncotarget_7456
crossref_primary_10_3390_ijms140917319
crossref_primary_10_1016_j_freeradbiomed_2013_10_811
crossref_primary_10_3390_ijms25073793
crossref_primary_10_1016_j_yexcr_2017_07_039
crossref_primary_10_1158_1078_0432_CCR_17_2485
crossref_primary_10_1016_j_ydbio_2016_01_041
crossref_primary_10_18632_oncotarget_23074
crossref_primary_10_3390_ijms14034934
crossref_primary_10_1093_nar_gku354
crossref_primary_10_1155_2012_762825
crossref_primary_10_1038_s41388_019_1025_x
crossref_primary_10_3390_ijms21197093
crossref_primary_10_1016_j_ccell_2020_01_003
crossref_primary_10_1016_j_scitotenv_2020_140591
crossref_primary_10_1021_es4055516
crossref_primary_10_1038_s41419_022_04976_6
crossref_primary_10_3109_07853890_2015_1043140
crossref_primary_10_1158_1055_9965_EPI_17_0728
crossref_primary_10_47482_acmr_1285642
crossref_primary_10_1080_14712598_2017_1340935
crossref_primary_10_1016_j_juro_2012_11_133
crossref_primary_10_1155_2021_8388258
crossref_primary_10_1038_s41598_021_84421_4
crossref_primary_10_1684_bdc_2012_1542
crossref_primary_10_1038_ncomms9583
crossref_primary_10_1038_aps_2013_35
crossref_primary_10_1186_s13046_020_01680_1
crossref_primary_10_1016_j_ygeno_2018_01_006
crossref_primary_10_1016_j_bios_2022_114900
crossref_primary_10_1155_2018_9207153
crossref_primary_10_1002_chem_201203344
crossref_primary_10_1074_jbc_M112_383273
crossref_primary_10_3389_fgene_2020_00219
crossref_primary_10_1093_carcin_bgac048
crossref_primary_10_1097_PAI_0000000000000169
crossref_primary_10_1126_sciadv_abb0737
crossref_primary_10_1007_s11357_017_0002_y
crossref_primary_10_1089_dna_2017_3633
crossref_primary_10_1007_s12094_020_02488_3
crossref_primary_10_1038_s41389_019_0150_2
crossref_primary_10_1038_s10038_020_0819_6
crossref_primary_10_3389_fimmu_2023_1151109
crossref_primary_10_1016_j_redox_2015_05_008
crossref_primary_10_1038_srep41241
crossref_primary_10_1016_j_gene_2019_05_034
crossref_primary_10_1002_jcb_28071
crossref_primary_10_1016_j_semcancer_2013_12_007
crossref_primary_10_1038_s41388_018_0577_5
crossref_primary_10_1158_1078_0432_CCR_20_0103
crossref_primary_10_1186_s13058_015_0652_6
crossref_primary_10_1016_j_biopha_2020_110228
crossref_primary_10_1128_MCB_00099_20
crossref_primary_10_1155_2020_3404059
crossref_primary_10_12677_ACM_2023_1351120
crossref_primary_10_1371_journal_pone_0068990
crossref_primary_10_1177_17590914221101704
crossref_primary_10_3324_haematol_2020_263756
crossref_primary_10_3390_ijms20215322
crossref_primary_10_1242_dev_153817
crossref_primary_10_3892_ijo_2019_4913
crossref_primary_10_1042_CS20140087
crossref_primary_10_1186_1471_2164_15_659
crossref_primary_10_1016_j_dci_2018_05_010
crossref_primary_10_1038_emm_2017_33
crossref_primary_10_3390_ijms21197117
crossref_primary_10_1073_pnas_2015808118
crossref_primary_10_1002_ctm2_1558
crossref_primary_10_1038_s41467_018_03556_7
crossref_primary_10_3390_biology11010023
crossref_primary_10_3390_genes12040552
crossref_primary_10_1530_REP_11_0240
crossref_primary_10_1016_j_mce_2015_07_030
crossref_primary_10_1016_j_ccr_2012_12_020
crossref_primary_10_1016_j_molonc_2015_04_015
crossref_primary_10_3389_fbioe_2022_813070
crossref_primary_10_1186_s43556_020_00004_1
crossref_primary_10_1097_BRS_0000000000004486
crossref_primary_10_1186_s13046_016_0289_z
crossref_primary_10_1002_cncr_32079
crossref_primary_10_1007_s00251_012_0677_2
crossref_primary_10_1016_j_yexmp_2018_11_014
crossref_primary_10_1155_2014_249393
crossref_primary_10_1016_j_redox_2018_03_016
crossref_primary_10_1016_j_prp_2019_01_001
crossref_primary_10_1016_j_cmet_2018_09_002
crossref_primary_10_1038_cddis_2016_64
crossref_primary_10_1186_1471_2407_12_627
crossref_primary_10_12938_bmfh_2021_067
crossref_primary_10_1038_nm_2593
crossref_primary_10_1042_CS20130079
crossref_primary_10_3390_ijms18061207
crossref_primary_10_3389_fonc_2021_823603
crossref_primary_10_1371_journal_pone_0193599
crossref_primary_10_1038_s41586_024_07336_w
crossref_primary_10_1002_cncr_28002
crossref_primary_10_1016_j_canlet_2013_06_027
crossref_primary_10_1016_j_canlet_2020_06_024
crossref_primary_10_1186_s13046_018_0796_1
crossref_primary_10_1016_j_biopha_2019_109303
crossref_primary_10_1111_are_12624
crossref_primary_10_1182_blood_2012_01_401794
crossref_primary_10_1038_s41598_017_09333_8
crossref_primary_10_1002_iub_2680
crossref_primary_10_3892_ijmm_2016_2553
crossref_primary_10_1111_1365_2435_12477
crossref_primary_10_3390_cancers13143485
crossref_primary_10_1002_mc_22286
crossref_primary_10_1111_apm_12514
crossref_primary_10_1016_j_biopha_2019_108960
crossref_primary_10_1016_j_cellsig_2013_09_006
crossref_primary_10_1089_ars_2019_7918
crossref_primary_10_1111_aogs_12883
crossref_primary_10_1002_ijc_28056
crossref_primary_10_1016_j_heliyon_2023_e22011
crossref_primary_10_1089_ars_2016_6643
crossref_primary_10_1016_j_mrgentox_2013_04_020
crossref_primary_10_1007_s10126_020_09982_3
crossref_primary_10_3892_or_2015_3866
crossref_primary_10_1038_s41388_020_1288_2
crossref_primary_10_1155_2017_2398696
crossref_primary_10_3389_fonc_2020_01533
crossref_primary_10_3390_cancers13153840
crossref_primary_10_7759_cureus_49880
crossref_primary_10_1016_j_mad_2017_08_013
crossref_primary_10_1016_j_ygyno_2014_03_575
crossref_primary_10_18632_genesandcancer_144
crossref_primary_10_1111_liv_12737
crossref_primary_10_1158_1078_0432_CCR_13_3224
crossref_primary_10_3892_ijo_2017_3915
crossref_primary_10_1007_s10456_018_9654_1
crossref_primary_10_1186_s12943_022_01588_8
crossref_primary_10_1002_jcb_30506
crossref_primary_10_1016_j_phrs_2018_09_021
crossref_primary_10_1093_toxsci_kfac066
crossref_primary_10_3389_fonc_2020_01084
crossref_primary_10_1016_j_arr_2012_10_004
crossref_primary_10_1016_j_envint_2019_105055
crossref_primary_10_1158_1078_0432_CCR_18_0784
crossref_primary_10_1016_j_canlet_2013_11_004
crossref_primary_10_3892_mmr_2022_12878
crossref_primary_10_3109_10715762_2013_772604
crossref_primary_10_1016_j_ygyno_2020_11_018
crossref_primary_10_1038_onc_2012_433
crossref_primary_10_1007_s11033_014_3045_5
crossref_primary_10_1002_jcb_29299
crossref_primary_10_1038_onc_2013_597
crossref_primary_10_1186_1471_2164_15_709
crossref_primary_10_1371_journal_pone_0174300
crossref_primary_10_1158_0008_5472_CAN_16_1615
crossref_primary_10_1016_j_fsi_2013_03_353
crossref_primary_10_1155_2018_2754941
crossref_primary_10_1186_s12864_016_3001_y
crossref_primary_10_1002_cbf_3694
crossref_primary_10_1002_jcp_29724
crossref_primary_10_1186_1471_2164_15_10
crossref_primary_10_1111_cas_16085
crossref_primary_10_1186_s12933_023_01842_3
crossref_primary_10_1016_j_freeradbiomed_2013_06_009
crossref_primary_10_1155_2022_2751696
crossref_primary_10_3390_cimb44120438
crossref_primary_10_1007_s40495_016_0051_4
crossref_primary_10_1038_s41598_018_25900_z
crossref_primary_10_3390_cancers13235878
crossref_primary_10_1038_s41598_021_84953_9
crossref_primary_10_1530_JME_13_0294
crossref_primary_10_3389_fendo_2022_856667
crossref_primary_10_2217_fon_15_251
crossref_primary_10_3389_fgene_2020_00705
crossref_primary_10_1371_journal_pone_0120159
crossref_primary_10_1038_s41420_021_00775_8
crossref_primary_10_1371_journal_pone_0101899
crossref_primary_10_1186_s13073_021_00888_w
crossref_primary_10_3892_or_2013_2267
crossref_primary_10_1038_s41598_017_15342_4
crossref_primary_10_1158_1535_7163_MCT_13_0296
crossref_primary_10_3390_ijerph17082766
crossref_primary_10_1038_aps_2017_164
crossref_primary_10_3390_cells9010169
crossref_primary_10_1002_jcb_27326
crossref_primary_10_3390_cancers13112680
crossref_primary_10_1016_j_bbcan_2023_189036
crossref_primary_10_3390_ijms18071560
crossref_primary_10_1016_j_jtherbio_2018_05_008
crossref_primary_10_1016_j_prp_2015_09_014
crossref_primary_10_1038_s41388_021_02067_y
crossref_primary_10_1517_14712598_2012_711309
crossref_primary_10_1016_j_trsl_2016_10_001
crossref_primary_10_1261_rna_063941_117
Cites_doi 10.1016/j.cell.2009.07.011
10.1016/j.cell.2009.11.020
10.1677/ERC-10-0148
10.1016/S0140-6736(09)61338-6
10.1158/0008-5472.CAN-06-1894
10.1155/2010/821717
10.1038/nature10167
10.1158/1078-0432.CCR-07-1731
10.1016/S0891-5849(99)00242-7
10.1038/ncb1998
10.1515/BC.2006.167
10.1007/s00018-009-0099-y
10.1158/0008-5472.CAN-05-1162
10.1002/emmm.201000073
10.1002/ijc.25461
10.1101/gad.1820109
10.1084/jem.20110235
10.1074/jbc.M806920200
10.1016/j.cell.2004.08.025
10.1038/sj.cdd.4402222
10.1158/0008-5472.CAN-08-1942
10.4049/jimmunol.0900006
10.1038/nrc2694
10.1016/j.molcel.2010.05.018
10.1186/1755-8794-1-59
10.1016/j.ccr.2007.01.009
10.1038/embor.2008.74
10.1038/ncb2173
10.1371/journal.pone.0005311
10.1016/j.bbadis.2009.12.009
10.1371/journal.pone.0006377
10.1038/ncb1722
10.1016/j.ccr.2006.12.013
10.1158/0008-5472.CAN-07-1058
10.1016/j.ygyno.2009.05.022
10.1186/1471-2407-10-222
10.1158/0008-5472.CAN-07-1936
10.1007/s10555-010-9225-4
10.1158/1535-7163.MCT-09-0965
10.1101/gad.1640608
10.1101/gad.1820209
10.1158/0008-5472.CAN-06-3914
10.1158/1078-0432.CCR-08-0196
10.1016/j.brainres.2010.05.059
10.1016/j.biocel.2010.01.014
10.1016/j.ygyno.2009.04.024
10.1016/S1470-2045(11)70012-2
10.1074/jbc.C800074200
10.1016/j.cmet.2007.12.010
10.1016/j.ygyno.2009.08.009
10.1111/j.1582-4934.2008.00398.x
10.1016/j.biocel.2009.12.017
10.1158/0008-5472.CAN-07-2488
10.1083/jcb.200807026
10.1038/cdd.2011.42
10.1016/j.molcel.2010.08.013
10.1038/ng2033
10.1016/j.cell.2007.09.020
10.1016/j.ygyno.2010.01.010
10.1038/nature10166
ContentType Journal Article
Copyright Springer Nature America, Inc. 2011
COPYRIGHT 2011 Nature Publishing Group
Copyright Nature Publishing Group Dec 2011
Copyright_xml – notice: Springer Nature America, Inc. 2011
– notice: COPYRIGHT 2011 Nature Publishing Group
– notice: Copyright Nature Publishing Group Dec 2011
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
IOV
ISR
3V.
7QG
7QL
7QP
7QR
7T5
7TK
7TM
7TO
7U7
7U9
7X7
7XB
88A
88E
88I
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M2P
M7N
M7P
MBDVC
P64
PQEST
PQQKQ
PQUKI
Q9U
RC3
DOI 10.1038/nm.2512
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Opposing Viewpoints Resource Center
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library
Science Database (ProQuest)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
Genetics Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
Health Research Premium Collection
Natural Science Collection
Biological Science Collection
Chemoreception Abstracts
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central Basic
Toxicology Abstracts
ProQuest Science Journals
ProQuest SciTech Collection
ProQuest Medical Library
Animal Behavior Abstracts
Immunology Abstracts
ProQuest Central (Alumni)
DatabaseTitleList Research Library Prep
MEDLINE



Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1546-170X
EndPage 1635
ExternalDocumentID 2643060681
A274955210
10_1038_nm_2512
22101765
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.-4
.55
.GJ
0R~
123
1CY
29M
2FS
36B
39C
3O-
3V.
4.4
53G
5BI
5M7
5RE
5S5
70F
7X7
85S
88A
88E
88I
8AO
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AAEEF
AARCD
AAYOK
AAZLF
ABAWZ
ABCQX
ABDBF
ABEFU
ABJNI
ABLJU
ABOCM
ABUWG
ABVXF
ACGFO
ACGFS
ACGOD
ACIWK
ACMJI
ACPRK
ADBBV
ADFRT
AENEX
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGCDD
AGEZK
AGHTU
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
ARMCB
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CCPQU
CS3
DB5
DU5
DWQXO
EAD
EAP
EBC
EBD
EBS
EE.
EJD
EMB
EMK
EMOBN
EPL
ESX
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
G8K
GNUQQ
GUQSH
GX1
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IEA
IH2
IHR
IHW
INH
INR
IOF
IOV
ISR
ITC
J5H
L7B
LGEZI
LK8
LOTEE
M0L
M1P
M2O
M2P
M7P
MK0
N9A
NADUK
NNMJJ
NXXTH
O9-
ODYON
P2P
PQQKQ
PROAC
PSQYO
Q2X
RIG
RNS
RNT
RNTTT
RVV
SHXYY
SIXXV
SJN
SNYQT
SV3
TAE
TAOOD
TBHMF
TDRGL
TSG
TUS
UKHRP
UQL
X7M
XJT
YHZ
ZGI
~8M
AAYZH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACBWK
CITATION
AAEXX
ABEEJ
ADZGE
AADEA
7QG
7QL
7QP
7QR
7T5
7TK
7TM
7TO
7U7
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
MBDVC
P64
PQEST
PQUKI
Q9U
RC3
ID FETCH-LOGICAL-c611t-6a61e919009906dfafab3f6a1454c69b0d38366f8f6e5ce77170c9845a4766693
IEDL.DBID 7X7
ISSN 1078-8956
IngestDate Tue Nov 19 06:42:12 EST 2024
Tue Nov 19 20:35:27 EST 2024
Thu Nov 14 20:43:28 EST 2024
Tue Nov 12 23:25:49 EST 2024
Thu Aug 01 19:28:29 EDT 2024
Thu Aug 01 19:32:37 EDT 2024
Tue Aug 20 21:54:56 EDT 2024
Fri Dec 06 01:18:29 EST 2024
Wed Oct 16 00:48:20 EDT 2024
Fri Oct 11 20:52:16 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c611t-6a61e919009906dfafab3f6a1454c69b0d38366f8f6e5ce77170c9845a4766693
PMID 22101765
PQID 1009160928
PQPubID 33975
PageCount 9
ParticipantIDs proquest_journals_1009160928
gale_infotracmisc_A274955210
gale_infotracgeneralonefile_A274955210
gale_infotracacademiconefile_A274955210
gale_incontextgauss_ISR_A274955210
gale_incontextgauss_IOV_A274955210
gale_healthsolutions_A274955210
crossref_primary_10_1038_nm_2512
pubmed_primary_22101765
springer_journals_10_1038_nm_2512
PublicationCentury 2000
PublicationDate 2011-12-01
PublicationDateYYYYMMDD 2011-12-01
PublicationDate_xml – month: 12
  year: 2011
  text: 2011-12-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Nature medicine
PublicationTitleAbbrev Nat Med
PublicationTitleAlternate Nat Med
PublicationYear 2011
Publisher Nature Publishing Group US
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group US
– name: Nature Publishing Group
References Hui (CR12) 2007; 39
van Jaarsveld, Helleman, Berns, Wiemer (CR44) 2010; 42
Cochrane, Howe, Spoelstra, Richer (CR42) 2010; 2010
Gerald (CR4) 2004; 118
Ramanathan (CR34) 2005; 65
Kim, Choi (CR15) 2010; 1802
Olson (CR48) 2009; 23
Lin (CR18) 2009; 284
Hyun (CR54) 2009; 139
Flynt (CR55) 2009; 185
Wang (CR20) 2010; 1346
Wada (CR13) 2008; 15
Hennessy, Coleman, Markman (CR1) 2009; 374
Laurent (CR6) 2008; 7
Burk (CR24) 2008; 9
Marchini (CR52) 2011; 12
CR2
Allen, Tresini (CR3) 2000; 28
Magenta (CR21) 2011; 18
Mezzanzanica, Bagnoli, De Cecco, Valeri, Canevari (CR43) 2010; 42
Chang (CR32) 2011; 13
Simone (CR19) 2009; 4
Wyman (CR47) 2009; 4
Wagner, Nebreda (CR14) 2009; 9
Nam (CR39) 2008; 14
Yang (CR46) 2008; 68
Eitan (CR51) 2009; 114
Weinberg, Chandel (CR7) 2009; 66
Shimono (CR28) 2009; 138
Hurteau, Carlson, Spivack, Brock (CR22) 2007; 67
Iliopoulos (CR30) 2010; 39
Konstantinopoulos (CR36) 2008; 1
Iorio (CR38) 2007; 67
Pouysségur, Mechta-Grigoriou (CR5) 2006; 387
Hu (CR40) 2009; 114
Tothill (CR45) 2008; 14
Raj (CR59) 2011; 475
Kennedy, Cellurale, Davis (CR11) 2007; 11
Leskelä (CR58) 2011; 18
Schickel, Park, Murmann, Peter (CR31) 2010; 38
Bracken (CR23) 2008; 68
Bendoraite (CR41) 2010; 116
Toullec (CR9) 2010; 2
Karres, Hilgers, Carrera, Treisman, Cohen (CR53) 2007; 131
Liu (CR37) 2010; 9
Korpal, Lee, Hu, Kang (CR26) 2008; 283
Gregory (CR25) 2008; 10
Park, Gaur, Lengyel, Peter (CR27) 2008; 22
Alexandre, Hu, Lu, Pelicano, Huang (CR35) 2007; 67
Marsit, Eddy, Kelsey (CR16) 2006; 66
Gibbons (CR49) 2009; 23
Helleman, Smid, Jansen, van der Burg, Berns (CR57) 2010; 117
Ivan, Harris, Martelli, Kulshreshtha (CR17) 2008; 12
Wellner (CR29) 2009; 11
Wiklund (CR50) 2011; 128
Naidu, Vijayan, Santoso, Kietzmann, Immenschuh (CR56) 2009; 182
Meyniel (CR60) 2010; 10
Kim (CR33) 2011; 208
Pani, Galeotti, Chiarugi (CR8) 2010; 29
Dolado (CR10) 2007; 11
22146456 - Nat Med. 2011 Dec;17(12):1552-4
PA Konstantinopoulos (BFnm2512_CR36) 2008; 1
L Hui (BFnm2512_CR12) 2007; 39
SK Wyman (BFnm2512_CR47) 2009; 4
L Raj (BFnm2512_CR59) 2011; 475
J Alexandre (BFnm2512_CR35) 2007; 67
MV Iorio (BFnm2512_CR38) 2007; 67
DR Cochrane (BFnm2512_CR42) 2010; 2010
GJ Hurteau (BFnm2512_CR22) 2007; 67
Y Lin (BFnm2512_CR18) 2009; 284
A Magenta (BFnm2512_CR21) 2011; 18
A Bendoraite (BFnm2512_CR41) 2010; 116
S Leskelä (BFnm2512_CR58) 2011; 18
P Olson (BFnm2512_CR48) 2009; 23
ED Wiklund (BFnm2512_CR50) 2011; 128
A Toullec (BFnm2512_CR9) 2010; 2
D Mezzanzanica (BFnm2512_CR43) 2010; 42
DL Gibbons (BFnm2512_CR49) 2009; 23
M Ivan (BFnm2512_CR17) 2008; 12
R Eitan (BFnm2512_CR51) 2009; 114
S Marchini (BFnm2512_CR52) 2011; 12
BT Hennessy (BFnm2512_CR1) 2009; 374
S Hyun (BFnm2512_CR54) 2009; 139
EF Wagner (BFnm2512_CR14) 2009; 9
EK Kim (BFnm2512_CR15) 2010; 1802
Y Shimono (BFnm2512_CR28) 2009; 138
MT van Jaarsveld (BFnm2512_CR44) 2010; 42
CJ Chang (BFnm2512_CR32) 2011; 13
BFnm2512_CR2
X Hu (BFnm2512_CR40) 2009; 114
U Burk (BFnm2512_CR24) 2008; 9
G Laurent (BFnm2512_CR6) 2008; 7
H Liu (BFnm2512_CR37) 2010; 9
RG Allen (BFnm2512_CR3) 2000; 28
NJ Kennedy (BFnm2512_CR11) 2007; 11
NL Simone (BFnm2512_CR19) 2009; 4
D Iliopoulos (BFnm2512_CR30) 2010; 39
CJ Marsit (BFnm2512_CR16) 2006; 66
B Ramanathan (BFnm2512_CR34) 2005; 65
PA Gregory (BFnm2512_CR25) 2008; 10
J Pouysségur (BFnm2512_CR5) 2006; 387
JS Karres (BFnm2512_CR53) 2007; 131
I Dolado (BFnm2512_CR10) 2007; 11
D Gerald (BFnm2512_CR4) 2004; 118
Z Wang (BFnm2512_CR20) 2010; 1346
S Naidu (BFnm2512_CR56) 2009; 182
F Weinberg (BFnm2512_CR7) 2009; 66
M Korpal (BFnm2512_CR26) 2008; 283
G Pani (BFnm2512_CR8) 2010; 29
U Wellner (BFnm2512_CR29) 2009; 11
AS Flynt (BFnm2512_CR55) 2009; 185
R Schickel (BFnm2512_CR31) 2010; 38
H Yang (BFnm2512_CR46) 2008; 68
EJ Nam (BFnm2512_CR39) 2008; 14
T Wada (BFnm2512_CR13) 2008; 15
J Helleman (BFnm2512_CR57) 2010; 117
RW Tothill (BFnm2512_CR45) 2008; 14
JP Meyniel (BFnm2512_CR60) 2010; 10
SM Park (BFnm2512_CR27) 2008; 22
T Kim (BFnm2512_CR33) 2011; 208
CP Bracken (BFnm2512_CR23) 2008; 68
References_xml – volume: 138
  start-page: 592
  year: 2009
  end-page: 603
  ident: CR28
  article-title: Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells
  publication-title: Cell
  doi: 10.1016/j.cell.2009.07.011
  contributor:
    fullname: Shimono
– volume: 139
  start-page: 1096
  year: 2009
  end-page: 1108
  ident: CR54
  article-title: Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.020
  contributor:
    fullname: Hyun
– volume: 18
  start-page: 85
  year: 2011
  end-page: 95
  ident: CR58
  article-title: The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
  publication-title: Endocr. Relat. Cancer
  doi: 10.1677/ERC-10-0148
  contributor:
    fullname: Leskelä
– volume: 374
  start-page: 1371
  year: 2009
  end-page: 1382
  ident: CR1
  article-title: Ovarian cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)61338-6
  contributor:
    fullname: Markman
– volume: 66
  start-page: 10843
  year: 2006
  end-page: 10848
  ident: CR16
  article-title: MicroRNA responses to cellular stress
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-1894
  contributor:
    fullname: Kelsey
– volume: 2010
  start-page: 821717
  year: 2010
  ident: CR42
  article-title: Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers
  publication-title: J. Oncol.
  doi: 10.1155/2010/821717
  contributor:
    fullname: Richer
– volume: 475
  start-page: 231
  year: 2011
  end-page: 234
  ident: CR59
  article-title: Selective killing of cancer cells by a small molecule targeting the stress response to ROS
  publication-title: Nature
  doi: 10.1038/nature10167
  contributor:
    fullname: Raj
– volume: 14
  start-page: 2690
  year: 2008
  end-page: 2695
  ident: CR39
  article-title: MicroRNA expression profiles in serous ovarian carcinoma
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-07-1731
  contributor:
    fullname: Nam
– volume: 28
  start-page: 463
  year: 2000
  end-page: 499
  ident: CR3
  article-title: Oxidative stress and gene regulation
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/S0891-5849(99)00242-7
  contributor:
    fullname: Tresini
– volume: 11
  start-page: 1487
  year: 2009
  end-page: 1495
  ident: CR29
  article-title: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1998
  contributor:
    fullname: Wellner
– volume: 387
  start-page: 1337
  year: 2006
  end-page: 1346
  ident: CR5
  article-title: Redox regulation of the hypoxia-inducible factor
  publication-title: Biol. Chem.
  doi: 10.1515/BC.2006.167
  contributor:
    fullname: Mechta-Grigoriou
– volume: 66
  start-page: 3663
  year: 2009
  end-page: 3673
  ident: CR7
  article-title: Reactive oxygen species–dependent signaling regulates cancer
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-009-0099-y
  contributor:
    fullname: Chandel
– volume: 65
  start-page: 8455
  year: 2005
  end-page: 8460
  ident: CR34
  article-title: Resistance to paclitaxel is proportional to cellular total antioxidant capacity
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-1162
  contributor:
    fullname: Ramanathan
– volume: 2
  start-page: 211
  year: 2010
  end-page: 230
  ident: CR9
  article-title: Oxidative stress promotes myofibroblast differentiation and tumour spreading
  publication-title: EMBO Mol. Med.
  doi: 10.1002/emmm.201000073
  contributor:
    fullname: Toullec
– volume: 128
  start-page: 1327
  year: 2011
  end-page: 1334
  ident: CR50
  article-title: Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.25461
  contributor:
    fullname: Wiklund
– volume: 23
  start-page: 2152
  year: 2009
  end-page: 2165
  ident: CR48
  article-title: MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
  publication-title: Genes Dev.
  doi: 10.1101/gad.1820109
  contributor:
    fullname: Olson
– volume: 208
  start-page: 875
  year: 2011
  end-page: 883
  ident: CR33
  article-title: p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20110235
  contributor:
    fullname: Kim
– volume: 284
  start-page: 7903
  year: 2009
  end-page: 7913
  ident: CR18
  article-title: Involvement of microRNAs in hydrogen peroxide–mediated gene regulation and cellular injury response in vascular smooth muscle cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M806920200
  contributor:
    fullname: Lin
– volume: 118
  start-page: 781
  year: 2004
  end-page: 794
  ident: CR4
  article-title: JunD reduces tumor angiogenesis by protecting cells from oxidative stress
  publication-title: Cell
  doi: 10.1016/j.cell.2004.08.025
  contributor:
    fullname: Gerald
– volume: 15
  start-page: 89
  year: 2008
  end-page: 93
  ident: CR13
  article-title: Antagonistic control of cell fates by JNK and p38-MAPK signaling
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4402222
  contributor:
    fullname: Wada
– volume: 68
  start-page: 7846
  year: 2008
  end-page: 7854
  ident: CR23
  article-title: A double-negative feedback loop between ZEB1–SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-08-1942
  contributor:
    fullname: Bracken
– volume: 182
  start-page: 7048
  year: 2009
  end-page: 7057
  ident: CR56
  article-title: Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene expression via Nrf2
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0900006
  contributor:
    fullname: Immenschuh
– volume: 9
  start-page: 537
  year: 2009
  end-page: 549
  ident: CR14
  article-title: Signal integration by JNK and p38 MAPK pathways in cancer development
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2694
  contributor:
    fullname: Nebreda
– volume: 38
  start-page: 908
  year: 2010
  end-page: 915
  ident: CR31
  article-title: miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2010.05.018
  contributor:
    fullname: Peter
– volume: 1
  start-page: 59
  year: 2008
  ident: CR36
  article-title: Carboplatin-induced gene expression changes are prognostic of survival in epithelial ovarian cancer
  publication-title: BMC Med. Genomics
  doi: 10.1186/1755-8794-1-59
  contributor:
    fullname: Konstantinopoulos
– volume: 11
  start-page: 101
  year: 2007
  end-page: 103
  ident: CR11
  article-title: A radical role for p38 MAPK in tumor initiation
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.01.009
  contributor:
    fullname: Davis
– volume: 9
  start-page: 582
  year: 2008
  end-page: 589
  ident: CR24
  article-title: A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
  publication-title: EMBO Rep.
  doi: 10.1038/embor.2008.74
  contributor:
    fullname: Burk
– volume: 13
  start-page: 317
  year: 2011
  end-page: 323
  ident: CR32
  article-title: p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb2173
  contributor:
    fullname: Chang
– volume: 4
  start-page: e5311
  year: 2009
  ident: CR47
  article-title: Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0005311
  contributor:
    fullname: Wyman
– ident: CR2
– volume: 1802
  start-page: 396
  year: 2010
  end-page: 405
  ident: CR15
  article-title: Pathological roles of MAPK signaling pathways in human diseases
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2009.12.009
  contributor:
    fullname: Choi
– volume: 4
  start-page: e6377
  year: 2009
  ident: CR19
  article-title: Ionizing radiation–induced oxidative stress alters miRNA expression
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0006377
  contributor:
    fullname: Simone
– volume: 10
  start-page: 593
  year: 2008
  end-page: 601
  ident: CR25
  article-title: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1722
  contributor:
    fullname: Gregory
– volume: 11
  start-page: 191
  year: 2007
  end-page: 205
  ident: CR10
  article-title: p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.12.013
  contributor:
    fullname: Dolado
– volume: 67
  start-page: 7972
  year: 2007
  end-page: 7976
  ident: CR22
  article-title: Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-1058
  contributor:
    fullname: Brock
– volume: 114
  start-page: 457
  year: 2009
  end-page: 464
  ident: CR40
  article-title: A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2009.05.022
  contributor:
    fullname: Hu
– volume: 10
  start-page: 222
  year: 2010
  ident: CR60
  article-title: A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-10-222
  contributor:
    fullname: Meyniel
– volume: 67
  start-page: 8699
  year: 2007
  end-page: 8707
  ident: CR38
  article-title: MicroRNA signatures in human ovarian cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-1936
  contributor:
    fullname: Iorio
– volume: 29
  start-page: 351
  year: 2010
  end-page: 378
  ident: CR8
  article-title: Metastasis: cancer cell′s escape from oxidative stress
  publication-title: Cancer Metastasis Rev.
  doi: 10.1007/s10555-010-9225-4
  contributor:
    fullname: Chiarugi
– volume: 9
  start-page: 1080
  year: 2010
  end-page: 1091
  ident: CR37
  article-title: mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-09-0965
  contributor:
    fullname: Liu
– volume: 22
  start-page: 894
  year: 2008
  end-page: 907
  ident: CR27
  article-title: The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
  publication-title: Genes Dev.
  doi: 10.1101/gad.1640608
  contributor:
    fullname: Peter
– volume: 23
  start-page: 2140
  year: 2009
  end-page: 2151
  ident: CR49
  article-title: Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
  publication-title: Genes Dev.
  doi: 10.1101/gad.1820209
  contributor:
    fullname: Gibbons
– volume: 67
  start-page: 3512
  year: 2007
  end-page: 3517
  ident: CR35
  article-title: Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-3914
  contributor:
    fullname: Huang
– volume: 14
  start-page: 5198
  year: 2008
  end-page: 5208
  ident: CR45
  article-title: Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-0196
  contributor:
    fullname: Tothill
– volume: 1346
  start-page: 14
  year: 2010
  end-page: 25
  ident: CR20
  article-title: Profiles of oxidative stress–related microRNA and mRNA expression in auditory cells
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2010.05.059
  contributor:
    fullname: Wang
– volume: 42
  start-page: 1282
  year: 2010
  end-page: 1290
  ident: CR44
  article-title: MicroRNAs in ovarian cancer biology and therapy resistance
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2010.01.014
  contributor:
    fullname: Wiemer
– volume: 114
  start-page: 253
  year: 2009
  end-page: 259
  ident: CR51
  article-title: Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2009.04.024
  contributor:
    fullname: Eitan
– volume: 12
  start-page: 273
  year: 2011
  end-page: 285
  ident: CR52
  article-title: Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(11)70012-2
  contributor:
    fullname: Marchini
– volume: 283
  start-page: 14910
  year: 2008
  end-page: 14914
  ident: CR26
  article-title: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.C800074200
  contributor:
    fullname: Kang
– volume: 7
  start-page: 113
  year: 2008
  end-page: 124
  ident: CR6
  article-title: Oxidative stress contributes to aging by enhancing pancreatic angiogenesis and insulin signaling
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2007.12.010
  contributor:
    fullname: Laurent
– volume: 116
  start-page: 117
  year: 2010
  end-page: 125
  ident: CR41
  article-title: Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2009.08.009
  contributor:
    fullname: Bendoraite
– volume: 12
  start-page: 1426
  year: 2008
  end-page: 1431
  ident: CR17
  article-title: Hypoxia response and microRNAs: no longer two separate worlds
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/j.1582-4934.2008.00398.x
  contributor:
    fullname: Kulshreshtha
– volume: 42
  start-page: 1262
  year: 2010
  end-page: 1272
  ident: CR43
  article-title: Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2009.12.017
  contributor:
    fullname: Canevari
– volume: 68
  start-page: 425
  year: 2008
  end-page: 433
  ident: CR46
  article-title: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-2488
  contributor:
    fullname: Yang
– volume: 185
  start-page: 115
  year: 2009
  end-page: 127
  ident: CR55
  article-title: miR-8 microRNAs regulate the response to osmotic stress in zebrafish embryos
  publication-title: J. Cell Biol.
  doi: 10.1083/jcb.200807026
  contributor:
    fullname: Flynt
– volume: 18
  start-page: 1628
  year: 2011
  end-page: 1639
  ident: CR21
  article-title: miR-200c is up-regulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2011.42
  contributor:
    fullname: Magenta
– volume: 39
  start-page: 761
  year: 2010
  end-page: 772
  ident: CR30
  article-title: Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2010.08.013
  contributor:
    fullname: Iliopoulos
– volume: 39
  start-page: 741
  year: 2007
  end-page: 749
  ident: CR12
  article-title: p38α suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway
  publication-title: Nat. Genet.
  doi: 10.1038/ng2033
  contributor:
    fullname: Hui
– volume: 131
  start-page: 136
  year: 2007
  end-page: 145
  ident: CR53
  article-title: The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in
  publication-title: Cell
  doi: 10.1016/j.cell.2007.09.020
  contributor:
    fullname: Cohen
– volume: 117
  start-page: 170
  year: 2010
  end-page: 176
  ident: CR57
  article-title: Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2010.01.010
  contributor:
    fullname: Berns
– volume: 475
  start-page: 231
  year: 2011
  ident: BFnm2512_CR59
  publication-title: Nature
  doi: 10.1038/nature10167
  contributor:
    fullname: L Raj
– volume: 67
  start-page: 3512
  year: 2007
  ident: BFnm2512_CR35
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-3914
  contributor:
    fullname: J Alexandre
– volume: 18
  start-page: 85
  year: 2011
  ident: BFnm2512_CR58
  publication-title: Endocr. Relat. Cancer
  doi: 10.1677/ERC-10-0148
  contributor:
    fullname: S Leskelä
– volume: 10
  start-page: 593
  year: 2008
  ident: BFnm2512_CR25
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1722
  contributor:
    fullname: PA Gregory
– volume: 65
  start-page: 8455
  year: 2005
  ident: BFnm2512_CR34
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-1162
  contributor:
    fullname: B Ramanathan
– ident: BFnm2512_CR2
  doi: 10.1038/nature10166
– volume: 185
  start-page: 115
  year: 2009
  ident: BFnm2512_CR55
  publication-title: J. Cell Biol.
  doi: 10.1083/jcb.200807026
  contributor:
    fullname: AS Flynt
– volume: 182
  start-page: 7048
  year: 2009
  ident: BFnm2512_CR56
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0900006
  contributor:
    fullname: S Naidu
– volume: 39
  start-page: 741
  year: 2007
  ident: BFnm2512_CR12
  publication-title: Nat. Genet.
  doi: 10.1038/ng2033
  contributor:
    fullname: L Hui
– volume: 374
  start-page: 1371
  year: 2009
  ident: BFnm2512_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)61338-6
  contributor:
    fullname: BT Hennessy
– volume: 67
  start-page: 8699
  year: 2007
  ident: BFnm2512_CR38
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-1936
  contributor:
    fullname: MV Iorio
– volume: 42
  start-page: 1262
  year: 2010
  ident: BFnm2512_CR43
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2009.12.017
  contributor:
    fullname: D Mezzanzanica
– volume: 117
  start-page: 170
  year: 2010
  ident: BFnm2512_CR57
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2010.01.010
  contributor:
    fullname: J Helleman
– volume: 42
  start-page: 1282
  year: 2010
  ident: BFnm2512_CR44
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2010.01.014
  contributor:
    fullname: MT van Jaarsveld
– volume: 14
  start-page: 2690
  year: 2008
  ident: BFnm2512_CR39
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-07-1731
  contributor:
    fullname: EJ Nam
– volume: 23
  start-page: 2152
  year: 2009
  ident: BFnm2512_CR48
  publication-title: Genes Dev.
  doi: 10.1101/gad.1820109
  contributor:
    fullname: P Olson
– volume: 15
  start-page: 89
  year: 2008
  ident: BFnm2512_CR13
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4402222
  contributor:
    fullname: T Wada
– volume: 2
  start-page: 211
  year: 2010
  ident: BFnm2512_CR9
  publication-title: EMBO Mol. Med.
  doi: 10.1002/emmm.201000073
  contributor:
    fullname: A Toullec
– volume: 18
  start-page: 1628
  year: 2011
  ident: BFnm2512_CR21
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2011.42
  contributor:
    fullname: A Magenta
– volume: 12
  start-page: 273
  year: 2011
  ident: BFnm2512_CR52
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(11)70012-2
  contributor:
    fullname: S Marchini
– volume: 28
  start-page: 463
  year: 2000
  ident: BFnm2512_CR3
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/S0891-5849(99)00242-7
  contributor:
    fullname: RG Allen
– volume: 29
  start-page: 351
  year: 2010
  ident: BFnm2512_CR8
  publication-title: Cancer Metastasis Rev.
  doi: 10.1007/s10555-010-9225-4
  contributor:
    fullname: G Pani
– volume: 38
  start-page: 908
  year: 2010
  ident: BFnm2512_CR31
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2010.05.018
  contributor:
    fullname: R Schickel
– volume: 131
  start-page: 136
  year: 2007
  ident: BFnm2512_CR53
  publication-title: Cell
  doi: 10.1016/j.cell.2007.09.020
  contributor:
    fullname: JS Karres
– volume: 10
  start-page: 222
  year: 2010
  ident: BFnm2512_CR60
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-10-222
  contributor:
    fullname: JP Meyniel
– volume: 66
  start-page: 10843
  year: 2006
  ident: BFnm2512_CR16
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-1894
  contributor:
    fullname: CJ Marsit
– volume: 9
  start-page: 582
  year: 2008
  ident: BFnm2512_CR24
  publication-title: EMBO Rep.
  doi: 10.1038/embor.2008.74
  contributor:
    fullname: U Burk
– volume: 139
  start-page: 1096
  year: 2009
  ident: BFnm2512_CR54
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.020
  contributor:
    fullname: S Hyun
– volume: 2010
  start-page: 821717
  year: 2010
  ident: BFnm2512_CR42
  publication-title: J. Oncol.
  doi: 10.1155/2010/821717
  contributor:
    fullname: DR Cochrane
– volume: 4
  start-page: e5311
  year: 2009
  ident: BFnm2512_CR47
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0005311
  contributor:
    fullname: SK Wyman
– volume: 7
  start-page: 113
  year: 2008
  ident: BFnm2512_CR6
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2007.12.010
  contributor:
    fullname: G Laurent
– volume: 23
  start-page: 2140
  year: 2009
  ident: BFnm2512_CR49
  publication-title: Genes Dev.
  doi: 10.1101/gad.1820209
  contributor:
    fullname: DL Gibbons
– volume: 9
  start-page: 1080
  year: 2010
  ident: BFnm2512_CR37
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-09-0965
  contributor:
    fullname: H Liu
– volume: 14
  start-page: 5198
  year: 2008
  ident: BFnm2512_CR45
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-0196
  contributor:
    fullname: RW Tothill
– volume: 66
  start-page: 3663
  year: 2009
  ident: BFnm2512_CR7
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-009-0099-y
  contributor:
    fullname: F Weinberg
– volume: 1
  start-page: 59
  year: 2008
  ident: BFnm2512_CR36
  publication-title: BMC Med. Genomics
  doi: 10.1186/1755-8794-1-59
  contributor:
    fullname: PA Konstantinopoulos
– volume: 13
  start-page: 317
  year: 2011
  ident: BFnm2512_CR32
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb2173
  contributor:
    fullname: CJ Chang
– volume: 387
  start-page: 1337
  year: 2006
  ident: BFnm2512_CR5
  publication-title: Biol. Chem.
  doi: 10.1515/BC.2006.167
  contributor:
    fullname: J Pouysségur
– volume: 11
  start-page: 191
  year: 2007
  ident: BFnm2512_CR10
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.12.013
  contributor:
    fullname: I Dolado
– volume: 1802
  start-page: 396
  year: 2010
  ident: BFnm2512_CR15
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2009.12.009
  contributor:
    fullname: EK Kim
– volume: 283
  start-page: 14910
  year: 2008
  ident: BFnm2512_CR26
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.C800074200
  contributor:
    fullname: M Korpal
– volume: 4
  start-page: e6377
  year: 2009
  ident: BFnm2512_CR19
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0006377
  contributor:
    fullname: NL Simone
– volume: 1346
  start-page: 14
  year: 2010
  ident: BFnm2512_CR20
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2010.05.059
  contributor:
    fullname: Z Wang
– volume: 114
  start-page: 253
  year: 2009
  ident: BFnm2512_CR51
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2009.04.024
  contributor:
    fullname: R Eitan
– volume: 11
  start-page: 101
  year: 2007
  ident: BFnm2512_CR11
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.01.009
  contributor:
    fullname: NJ Kennedy
– volume: 284
  start-page: 7903
  year: 2009
  ident: BFnm2512_CR18
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M806920200
  contributor:
    fullname: Y Lin
– volume: 22
  start-page: 894
  year: 2008
  ident: BFnm2512_CR27
  publication-title: Genes Dev.
  doi: 10.1101/gad.1640608
  contributor:
    fullname: SM Park
– volume: 208
  start-page: 875
  year: 2011
  ident: BFnm2512_CR33
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20110235
  contributor:
    fullname: T Kim
– volume: 128
  start-page: 1327
  year: 2011
  ident: BFnm2512_CR50
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.25461
  contributor:
    fullname: ED Wiklund
– volume: 118
  start-page: 781
  year: 2004
  ident: BFnm2512_CR4
  publication-title: Cell
  doi: 10.1016/j.cell.2004.08.025
  contributor:
    fullname: D Gerald
– volume: 9
  start-page: 537
  year: 2009
  ident: BFnm2512_CR14
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2694
  contributor:
    fullname: EF Wagner
– volume: 68
  start-page: 7846
  year: 2008
  ident: BFnm2512_CR23
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-08-1942
  contributor:
    fullname: CP Bracken
– volume: 138
  start-page: 592
  year: 2009
  ident: BFnm2512_CR28
  publication-title: Cell
  doi: 10.1016/j.cell.2009.07.011
  contributor:
    fullname: Y Shimono
– volume: 67
  start-page: 7972
  year: 2007
  ident: BFnm2512_CR22
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-1058
  contributor:
    fullname: GJ Hurteau
– volume: 39
  start-page: 761
  year: 2010
  ident: BFnm2512_CR30
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2010.08.013
  contributor:
    fullname: D Iliopoulos
– volume: 12
  start-page: 1426
  year: 2008
  ident: BFnm2512_CR17
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/j.1582-4934.2008.00398.x
  contributor:
    fullname: M Ivan
– volume: 11
  start-page: 1487
  year: 2009
  ident: BFnm2512_CR29
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1998
  contributor:
    fullname: U Wellner
– volume: 116
  start-page: 117
  year: 2010
  ident: BFnm2512_CR41
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2009.08.009
  contributor:
    fullname: A Bendoraite
– volume: 114
  start-page: 457
  year: 2009
  ident: BFnm2512_CR40
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2009.05.022
  contributor:
    fullname: X Hu
– volume: 68
  start-page: 425
  year: 2008
  ident: BFnm2512_CR46
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-2488
  contributor:
    fullname: H Yang
SSID ssj0003059
Score 2.594187
Snippet This report identifies a new contribution of members of the miR-200 family to tumorigenesis. miR-200a and miR-141 specifically regulate p38α, contributing to...
Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk...
SourceID proquest
gale
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1627
SubjectTerms 631/337/384/331
692/420/755
692/699/67/1517/1709
Adult
Aged
Aged, 80 and over
Animals
Antioxidants
Biomedical and Life Sciences
Biomedicine
Cancer Research
Carcinoma, Ovarian Epithelial
Cell Line, Tumor
Cell Proliferation
Cell Transformation, Neoplastic - genetics
Down-Regulation
Female
Gene expression
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Infectious Diseases
Metabolic Diseases
Mice
Mice, Nude
MicroRNA
MicroRNAs - genetics
MicroRNAs - metabolism
Middle Aged
Mitogen-Activated Protein Kinase 14 - genetics
Mitogen-Activated Protein Kinase 14 - metabolism
Molecular Medicine
Neoplasms, Glandular and Epithelial - genetics
Neoplasms, Glandular and Epithelial - pathology
Neurosciences
Ovarian cancer
Ovarian Neoplasms - genetics
Ovarian Neoplasms - pathology
Ovarian tumors
Oxidative Stress
Physiological aspects
Ribonucleic acid
RNA
Stress response
Tumors
Title miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
URI https://link.springer.com/article/10.1038/nm.2512
https://www.ncbi.nlm.nih.gov/pubmed/22101765
https://www.proquest.com/docview/1009160928
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Nb9MwFH-CTaBdEIyvwBgGITgZ4jRx4xNqYdVA2kCFoWoXy3HsqYcmW5Mi9t_zHLtlmRDilEj5JZJf3offpwFeGRQ-VbCUWmNjmgprqUg0p4ViSunYxFa5eMfRMT88ST_PslkIuDWhrHKtEztFXdbaxchRutGy8Vgk-fvzC-pOjXLZ1XCExk3YZgmacuTn4WzjcDleFr7mMKc5OgK-adaNBH9XLd46y96zRtd18hWjdC1L2hmfyV24E3aNZOR_8z24YapduOXPkbzchdtHIUN-H04X8yllKSOqKom7R_5UROmW1BWpf6JnrCrSrhZuaU7NzRtSXJJQsO5a00n9a15208CJ7yMhS19Gax7AyeTg-4dDGs5PoJoz1lKuODMCLb5LfvHSKquKgeWKpVmquSjiEt1Tzm1uucm0GaJnF2uRp5lKh-jViMFD2KrqyjwGYk2Gos_TokRzVuIuIi8QrpPYsNxkIo-ArOkoz_2YDNmltwe5rBbSkTqC546-0vd3bgRLjtAvFhnuIuIIXnYIN5aicnUvZ2rVNPLTlx__Afo27YHeBJCt26XSKvQa4GLcuKse8nUPeeaHff8NuNcDohTq_uM128igBRr5h2cjeORZaUOdJHHKkGcRvFjz1tUXe6R78u-PP4WdLtLdFdnswVa7XJlnuFVqi_1OHvZhezT-OJ7gdXxw_HX6GyrHESw
link.rule.ids 314,780,784,12056,21388,27924,27925,31719,33744,43310,43805,73745,74302
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFD6CTlxeEIxbYDCDEDwZkjTx7Cc00KYO1oLKNk28WI5jT31oMpoUsX_PceyWZUKIt0j5Eikn5-pzA3hlUPhUkWTUGhvTTFhLRaoZLVSilI5NbJU77xhP2Og4-3San4YDtyaUVa50Yqeoy1q7M3KUbrRsLBYpf3_-g7qtUS67GlZoXIcNNzk9H8DGh73J1-laFyM3C191yCnHUMC3zbqh4O-q-Vtn23v26KpWvmSWruRJO_OzfxfuBL-R7PoffQ-umWoTbvhNkhebcHMccuT34ft8NqVJlhBVlcRdI4cqonRL6orUPzE2VhVpl3P3cU7RzRpSXJBQsu6a00n9a1Z288CJ7yQhC19Iax7A8f7e0ccRDRsUqGZJ0lKmWGIE2nyX_mKlVVYVQ8tUkuWZZqKISwxQGbPcMpNrs4OxXawFz3KV7WBcI4YPYVDVlXkMxJochZ9lRYkGrUQ_ghcI12lsEm5ywSMgKzrKcz8oQ3YJ7iGX1Vw6Ukew7egrfYfnWrTkLkbGIkc_Io7gZYdwgykqV_lyppZNIw--nPwH6Nu0B3oTQLZuF0qr0G2AH-MGXvWQr3vIMz_u-2_ArR4Q5VD3b6_YRgY90Mg_XBvBI89Ka-qkqVOHLI_gxYq3Lj_YI92Tf798G26NjsaH8vBg8vkp3O7OvbuSmy0YtIuleYaOU1s8D9LxG6-EEnY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB7BVlRcKiivlEINQnAyjbOJG59Qga5aoEu1UFRxsRzHrvawSdlkEf33jGPv0lQIcYuUL5E8nofH8wJ4YVD4VMFSao2NaSqspSLRnBaKKaVjE1vl7juOx_zwNP1wlp2F_KcmpFUudWKnqMtauztylG60bDwWSb5rQ1rEyfvRm4sf1E2QcpHWME7jJqyhVYyTAay9PRifTFZ6GTlb-AzEnOboFvgSWtcgfLeavXZ2vmebrmvoKybqWsy0M0WjO7ARzpBk32_6Xbhhqk245adKXm7C-nGIl9-D77PphLKUEVWVxD0jtyqidEvqitQ_0U9WFWkXM7c4p_SmDSkuSUhfd4XqpP41Lbve4MRXlZC5T6o19-F0dPD13SEN0xSo5oy1lCvOjED770JhvLTKqmJouWJplmouirhEZ5Vzm1tuMm320M-LtcjTTKV76OOI4QMYVHVlHgGxJkNFwNOiRONW4pkiLxCuk9iw3GQij4As6SgvfNMM2QW7h7msZtKROoIdR1_pqz1XYib30UsWGZ4p4giedwjXpKJy232uFk0jjz5_-w_Ql0kP9CqAbN3OlVah8gAX45pf9ZAve8hz3_r7b8DtHhBlUvdfL9lGBp3QyD8cHMFDz0or6iSJU408i-DZkreuftgj3da_f74D6ygY8tPR-ONjuN1dgXfZN9swaOcL8wTPUG3xNAjHb8lZFqM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=miR-141+and+miR-200a+act+on+ovarian+tumorigenesis+by+controlling+oxidative+stress+response&rft.jtitle=Nature+medicine&rft.au=Mateescu%2C+Bogdan&rft.au=Batista%2C+Luciana&rft.au=Cardon%2C+Melissa&rft.au=Gruosso%2C+Tina&rft.date=2011-12-01&rft.eissn=1546-170X&rft.volume=17&rft.issue=12&rft.spage=1627&rft_id=info:doi/10.1038%2Fnm.2512&rft_id=info%3Apmid%2F22101765&rft.externalDocID=22101765
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-8956&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-8956&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-8956&client=summon